Concentration-effect relationship of intravenous alfentanil and ketamine on peripheral neurosensory thresholds, allodynia and hyperalgesia of neuropathic pain

Pain

Volumn 91, Issue 1-2, 2001, Pages 177-187

  Leung, Albert ^a   Wallace, Mark S ^a   Ridgeway, Beri ^b   Yaksh, Tony ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alfentanil; Allodynia; Hyperalgesia; Ketamine; Neuropathic pain; Post nerve injury pain

Indexed keywords

ALFENTANIL; DIPHENHYDRAMINE; KETAMINE; MU OPIATE RECEPTOR AGONIST; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ADULT; AGED; ALLODYNIA; ARTICLE; CLINICAL TRIAL; COLD; CONCENTRATION RESPONSE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG EFFECT; FEMALE; HUMAN; HYPERALGESIA; INFUSION PUMP; MALE; NERVE INJURY; PAIN; PAIN THRESHOLD; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; AGED, 80 AND OVER; ALFENTANIL; ANALGESICS; ANALGESICS, OPIOID; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; HUMANS; HYPERALGESIA; INJECTIONS, INTRAVENOUS; KETAMINE; MALE; MIDDLE AGED; NEURALGIA; OSMOLAR CONCENTRATION; PAIN MEASUREMENT; PAIN THRESHOLD; PERIPHERAL NERVES; TREATMENT OUTCOME;

EID: 0035056590     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(00)00433-4     Document Type: Article

References (68)

1. Neurosensory findings after oral mexiletine in healthy volunteers
2. Differential effects of epidural morphine in treatment of cancer related pain
3. Lack of analgesic effect of opioids on neuropathic and idiopathic form of pain
4. Reply to Howard Fields on 'can opiates relieve neuropathic pain?'
5. Opioids in neuropathic pain
6. Response of chronic neuropathic pain syndromes to ketamine: A preliminary study
7. Characterization of the anti-allodynic efficacy of morphine in a model of neuropathic pain in rats
8. Simultaneous determination of alfentanil and fontanel in rat tissues by capillary column gas chromatography
9. Dextrometrophan attenuates responses of spinothalamic tract cells in normal and nerve-injured monkeys
10. Evidence for the interaction of glutamate and NK1 receptor in the periphery
11. Opioid responsiveness of cancer pain syndromes caused by neuropathic or nociceptive mechanisms: A combined analysis of controlled single-dose studies
12. Ultrastructural analysis of NMDA, AMPA, and kainate receptors on unmyelinated and myelinated axons in the periphery
13. Opioid receptors on peripheral sensory axons
14. Supraspinal pathways and integration of pain and temperature
15. A new version of the thalamic disinhibition hypothesis of central pain
16. Intraplantar injection of dextromethorphan, ketamine or memantine attenuates formalin-induced behaviors
17. Are opioids effective in relieving neuropathic pain?
18. + channel immunolocalization in peripheral mammalian axons and changes following nerve injury and neuroma formation
19. The pharmacology of excitatory and inhibitory amino acid-mediated events in the transmission and modulation of pain in the spinal cord
20. A cure for wind up: NMDA receptor antagonists as potential analgesics
21. Spinal dorsal horn plasticity following tissue or nerve injury
22. Relief of post-herpetic neuralgia with the N-methyl-aspartic acid receptor antagonist ketamine: A double-blind cross-over comparison with morphine, and placebo
23. Development of a gas-chromatography-mass spectrometry method for determination of ketamine in plasma and its application to human samples
24. Multiple mechanisms of neuropathic pain: A clinical perspective
25. Multiple opiate receptor sites on primary afferent fibers
26. Prevention of postherpetic neuralgia by amantadine hydrochloride (Symmetrel)
27. Painful neuropathy: Altered central processing maintained dynamically by peripheral input
28. Dynorphin, a preferential ligand for kappa-opioid receptors, is present in nerve fibers and immune cells within inflamed tissue of the rat
29. Effect of systemic N-methyl-D-aspartate receptor antagonist (dextromethrophan) on primary and secondary hyperalgesia in humans
30. Intrathecal administration of a competitive NMDA receptor antagonist for pain treatment
31. The NMDA-receptor antagonist CPP abolishes neurogenic 'wind-up pain' after intrathecal administration in humans
32. Spinal cord morphology and antinociception after chronic intrathecal administration of excitatory amino acid antagonists in the rat
33. Axonal transport of opiate receptors in capsaicin sensitive neurons
34. Opiate receptor binding in primate spinal cord: Distribution and changes after dorsal root section
35. Pain, hyperalgesia and activity in nociceptive C units in humans after intradermal injection of capsaicin
36. Intravenous infusion of the NMDA antagonist, ketamine, in chronic post-traumatic pain with allodynia: A double-blind comparison to alfentanil and placebo
37. Peripheral nerve injury triggers noradrenergic sprouting within dorsal root ganglia
38. Multiple opioid systems and pain
39. High-dose oral dextromethrophan versus placebo in painful diabetic neuropathy and postherpetic neuralgia
40. Localization of opiate and histamine H1-recetors in the primary sensory ganglia and spinal cord
41. Chronic use of opioid analgesics in non-malignant pain: Report of 38 cases
42. The nature of opioid responsiveness and its implications for neuropathic pain: New hypotheses derived from studies of opioid infusions
43. The N-methyl-D-aspartate receptor antagonist dextromethrophan selectively reduces temporal summation of second pain in man
44. A comparison of pain measurement characteristics of mechanical visual analogue and simple numerical rating scales
45. The NMDA receptor antagonist amantadine reduces surgical neuropathic pain in cancer patients: A double blind, randomized, placebo controlled trial
46. Simultaneous extraction of sufentanil and midazolam from human plasma
47. Opiates inhibit the inhibits the discharge of fine afferent units from inflamed knee joint of the cat
48. Peripheral mechanism of opioid analgesia
49. Intrinsic mechanisms of antinociception in inflammation. Local opioid receptors and B-endorphin
50. Long-term treatment of chronic neuropathic pain with the NMDA (N-methyl-D-aspartate) receptor antagonist ketamine
51. Dextrorphan relieves neuropathic heat-evoked hyperalgesia in the rat
52. Opioid analgesics in the treatment of chronic intractable pain of non-neoplastic origin
53. Opioid analgesics in cancer pain: Current practice and controversies
54. Long-term use of narcotic/antidepressant medication in the management of phantom limb pain
55. Quantitative somatosensory thermotest: A key method for functional evaluation of small calibre afferent channels
56. Computer-controlled lidocaine infusion for the evaluation of neuropathic pain after peripheral nerve injury
57. Concentration-effect relationship for intravenous lidocaine infusions in human volunteers. Effects on acute sensory thresholds and capsaicin-evoked hyperalgesia
58. The NMDA receptor concept: Origins and development
59. Heterogeneous sensitivity of cultured mu- and delta-opiate receptors
60. Peripheral nerve injury triggers central sprouting of myelinated afferents
61. The spinal actions of opioids
62. Pharmacology and mechanisms of opioid analgesic activity
63. Spinal systems and pain processing: Development of novel analgesic drugs with mechanistically defined models
64. Reversal of nerve ligation-induced allodynia by spinal alpha-2 adrenoreceptor agonists
65. Spinal pharmacology of thermal hyperesthesia induced by incomplete ligation of sciatic nerve. I. Opioid and nonopioid receptors
66. Studies on the spinal interaction of morphine and the NMDA antagonist MK-801 on the hyperesthesia observed in a rat model of sciatic mononeuropathy
67. Warm and cold specific somatosensory systems. Psychophysical thresholds, reaction times and peripheral conduction velocities
68. Opioid receptors undergo axonal flow